Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of MT-102 for cancer cachexia in non-small cell lung cancer and colorectal cancer
2010-022486-10Phase 2Unknown
- Sponsor
- Myotec Therapeutics
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of s-pindolol benzoate in cancer anorexia-cachexia syndrome (CACS) (3 arms), sponsored by Myotec Therapeutics. Status: unknown.
02
Drugs
s-pindolol benzoate
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on 2010-022486-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022486-10.